Skip to content

John M. Evans, CEO at Beam Therapeutics, sold BEAM on Jun 29, 2026

Data as of Oct 16

▼ SELL$472K13,421 shares at $35.13John M. Evans CEOBEAM Beam Therapeutics Inc.
Watch BEAM
Traded
Jun 29, 2026
Disclosed
Jul 1, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

John M. Evans, CEO at Beam Therapeutics, sold BEAM on Jun 29, 2026TRADEDDISCLOSED
BEAMSimilar stocks (XLV — its sector index fund), rebased to BEAM's price on the disclosure day
BEAM since disclosure
−29.9%
after the sale
Similar stocks (XLV) since disclosure
+10.8%
XLV — its sector index fund

Change in closing price from Jul 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJohn M. Evans CEOBEAM Beam Therapeutics Inc.$791Kdisclosed Jul 1 · filed 1 day after the trade
  2. ▼ SELLJohn M. Evans CEOBEAM Beam Therapeutics Inc.$66.2Kdisclosed Jul 1 · filed 1 day after the trade
  3. ▼ SELLJohn M. Evans CEOBEAM Beam Therapeutics Inc.$416Kdisclosed Jul 1 · filed 2 days after the trade

See every trade on BEAM →